Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction

ConditionsHydronephrosis; Obstruction, Ureter Renal Failure Malignancy Ureter Obstruction Ureter Stricture

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorRabin Medical Center

About this trial

Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. This study aim to compare tandem 6 Fr Percuflex™ stents and single large-caliber 8Fr silicone stent in patients with MUO. The primary endpoint is stent failure rate. The secondary endpoints are patient comfort, quality of life and overall survival.

Eligibility criteria

Qualifiers

patient with malignant ureteral obstruction

Disqualifiers

ureteral obstruction of other causes

Language comprehension or other limitation in giving informed consent

Trial design

Treatments tested in this trial

ureteral stent\s insertion

Treatment groups

106 Participants

are divided into 2 treatment groups

Locations

Rabin Medical Center49414, Petah Tikva Israel

Sheba medical center Ramat Gan Israel

Sponsors and collaborators

Rabin Medical Center

Lead sponsor

Sheba Medical Center

Collaborator

Source ClinicalTrials.gov